These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16867864)

  • 21. Lipid cell (steroid cell) tumor of the ovary: immunophenotype with analysis of potential pitfall due to endogenous biotin-like activity.
    Seidman JD; Abbondanzo SL; Bratthauer GL
    Int J Gynecol Pathol; 1995 Oct; 14(4):331-8. PubMed ID: 8598336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: implications in tumor diagnosis.
    Miettinen M; Fetsch JF
    Hum Pathol; 2000 Sep; 31(9):1062-7. PubMed ID: 11014572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OCT4: a novel biomarker for dysgerminoma of the ovary.
    Cheng L; Thomas A; Roth LM; Zheng W; Michael H; Karim FW
    Am J Surg Pathol; 2004 Oct; 28(10):1341-6. PubMed ID: 15371950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibin alpha and beta expression in ovarian stromal tumors and their histological equivalences.
    Ciriş M; Erhan Y; Zekioglu O; Bayramoglu H
    Acta Obstet Gynecol Scand; 2004 May; 83(5):491-6. PubMed ID: 15059165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spindle epithelial tumor with thymus-like differentiation: a morphologic, immunohistochemical, and molecular genetic study of 11 cases.
    Folpe AL; Lloyd RV; Bacchi CE; Rosai J
    Am J Surg Pathol; 2009 Aug; 33(8):1179-86. PubMed ID: 19417583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
    Cao D; Guo S; Allan RW; Molberg KH; Peng Y
    Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testicular Sertoli cell tumor with a heterologous sarcomatous component: immunohistochemical assessment of Sertoli cell differentiation.
    Gilcrease MZ; Delgado R; Albores-Saavedra J
    Arch Pathol Lab Med; 1998 Oct; 122(10):907-11. PubMed ID: 9786352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of immunohistochemistry in confirming undifferentiated ovarian carcinomas.
    Georgescu CV; Florescu M; Simionescu C
    Rom J Morphol Embryol; 1999-2004; 45():133-42. PubMed ID: 15847387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
    Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
    Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical phenotype of ovarian granulosa cell tumors: absence of epithelial membrane antigen has diagnostic value.
    Costa MJ; DeRose PB; Roth LM; Brescia RJ; Zaloudek CJ; Cohen C
    Hum Pathol; 1994 Jan; 25(1):60-6. PubMed ID: 8314261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD30 expression in seminoma.
    Hittmair A; Rogatsch H; Hobisch A; Mikuz G; Feichtinger H
    Hum Pathol; 1996 Nov; 27(11):1166-71. PubMed ID: 8912826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens.
    Kanemitsu S; Hisaoka M; Shimajiri S; Matsuyama A; Hashimoto H
    Diagn Mol Pathol; 2007 Mar; 16(1):9-17. PubMed ID: 17471153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
    Esheba GE; Pate LL; Longacre TA
    Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of cytokeratins in gliomas.
    Goswami C; Chatterjee U; Sen S; Chatterjee S; Sarkar S
    Indian J Pathol Microbiol; 2007 Jul; 50(3):478-81. PubMed ID: 17883112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA fragmentation factor (DFF45): expression and prognostic value in serous ovarian cancer.
    Brustmann H
    Pathol Res Pract; 2006; 202(10):713-20. PubMed ID: 16962250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the CD30 antigen in non-lymphoid tissues and cells.
    Dürkop H; Foss HD; Eitelbach F; Anagnostopoulos I; Latza U; Pileri S; Stein H
    J Pathol; 2000 Apr; 190(5):613-8. PubMed ID: 10727988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical profiling of cytokeratin expression by endometrial stroma sarcoma.
    Adegboyega PA; Qiu S
    Hum Pathol; 2008 Oct; 39(10):1459-64. PubMed ID: 18619644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokeratin immunoreactivity in malignant fibrous histiocytoma and spindle cell tumors: comparison between frozen and paraffin-embedded tissues.
    Litzky LA; Brooks JJ
    Mod Pathol; 1992 Jan; 5(1):30-4. PubMed ID: 1371872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical study of rhabdomyosarcoma. Unexpected staining with S100 protein and cytokeratin.
    Coindre JM; de Mascarel A; Trojani M; de Mascarel I; Pages A
    J Pathol; 1988 Jun; 155(2):127-32. PubMed ID: 2455782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.